BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31972635)

  • 1. Role of primary retroperitoneal lymph node dissection in stage I and low-volume metastatic germ cell tumors.
    Heidenreich A; Paffenholz P; Nestler T; Pfister D; Daneshmand S
    Curr Opin Urol; 2020 Mar; 30(2):251-257. PubMed ID: 31972635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.
    Heidenreich A; Paffenholz P; Nestler T; Pfister D
    Oncol Res Treat; 2018; 41(6):370-378. PubMed ID: 29772568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
    Heidenreich A; Pfister D
    Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Effectiveness of Risk-adapted Surveillance vs Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: A Retrospective Follow-up Study of 81 Patients.
    Fan G; Zhang L; Yi L; Jiang ZQ; Ke Y; Wang XS; Xiong YY; Han WQ; Zhou X; Liu C; Yu X
    Asian Pac J Cancer Prev; 2015; 16(8):3267-72. PubMed ID: 25921130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
    Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
    Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND)].
    Nicolai N; Necchi A; Piva L; Stagni S; Catanzaro MA; Biasoni D; Milani A; Torelli T; Salvioni R
    Urologia; 2010; 77(2):84-7. PubMed ID: 20890864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Metastatic Seminoma: Results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS).
    Heidenreich A; Paffenholz P; Hartmann F; Seelemeyer F; Pfister D
    Eur Urol Oncol; 2024 Feb; 7(1):122-127. PubMed ID: 37438222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term results of laparoscopic retroperitoneal lymph node dissection (RPLND) in low-stage nonseminomatous germ-cell testicular tumors (NSGCTT) performed by a senior surgeon: 1999-2003].
    Pizzocaro G; Schiavo M; Solima S; Vitellaro M; Biasoni N; Nicolai N
    Urologia; 2010; 77 Suppl 17():50-6. PubMed ID: 21308676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?
    Tachibana I; Kern SQ; Douglawi A; Tong Y; Mahmoud M; Masterson TA; Adra N; Foster RS; Einhorn LH; Cary C
    J Clin Oncol; 2022 Nov; 40(32):3762-3769. PubMed ID: 35675585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of patients with low-stage nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Sheinfeld J
    Curr Treat Options Oncol; 2005 Sep; 6(5):367-77. PubMed ID: 16107240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Retroperitoneal Lymph Node Dissection in Stage I and Low-volume Metastatic Germ Cell Tumors.
    Alsyouf M; Daneshmand S
    Eur Urol Focus; 2023 Mar; 9(2):248-250. PubMed ID: 36707277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes.
    Woldu SL; Moore JA; Ci B; Freifeld Y; Clinton TN; Aydin AM; Singla N; Laura-Maria K; Hutchinson RC; Amatruda JF; Sagalowsky A; Lotan Y; Arriaga Y; Margulis V; Xie Y; Bagrodia A
    Eur Urol Oncol; 2018 Aug; 1(3):242-251. PubMed ID: 31058267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.
    Daneshmand S; Cary C; Masterson T; Einhorn L; Adra N; Boorjian SA; Kollmannsberger C; Schuckman A; So A; Black P; Bagrodia A; Skinner E; Alemozaffar M; Brand T; Eggener S; Pierorazio P; Stratton K; Nappi L; Nichols C; Luo C; Li M; Hu B
    J Clin Oncol; 2023 Jun; 41(16):3009-3018. PubMed ID: 36913642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current controversies on the role of retroperitoneal lymphadenectomy for testicular cancer.
    Mano R; Di Natale R; Sheinfeld J
    Urol Oncol; 2019 Mar; 37(3):209-218. PubMed ID: 30446455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
    Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
    J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of low-stage nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Klein EA
    BJU Int; 2009 Nov; 104(9 Pt B):1362-8. PubMed ID: 19840014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of retroperitoneal lymph node dissection for testicular cancer in the United States: Results from the National Cancer Database (1998-2011).
    Hugen CM; Hu B; Jeldres C; Burton C; Nichols CR; Porter CR; Daneshmand S
    Urol Oncol; 2016 Nov; 34(11):487.e7-487.e11. PubMed ID: 27372281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy.
    Mazzone E; Mistretta FA; Knipper S; Tian Z; Palumbo C; Gandaglia G; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Dec; 17(6):e1153-e1162. PubMed ID: 31515197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014.
    Tabakin AL; Shinder BM; Kim S; Rivera-Nunez Z; Polotti CF; Modi PK; Sterling JA; Farber NJ; Radadia KD; Parikh RR; Kim IY; Saraiya B; Mayer TM; Singer EA; Jang TL
    Clin Genitourin Cancer; 2020 Apr; 18(2):e194-e201. PubMed ID: 31818649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.